Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis

Eye

Volumn 20, Issue 8, 2006, Pages 934-937

  Das Bhaumik, R G ^a   Jones, N P ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; CHLORAMPHENICOL; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; LOW DRUG DOSE; MALE; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; UVEITIS; VISUAL ACUITY;

EID: 33747068592     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702063     Document Type: Article

References (17)

1. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitis cystoid macular edema: An optical coherence tomography study Ophthalmology 2001; 108: 765-772.
2. Sanchez JM, Sanchez J. Intravitreal injection of triamcinolone acetonide in non infectious uveitis. Arch Soc Esp Oftalmol 2001; 76: 661-664.
3. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001; 29: 2-6.
4. Tano Y, Chandler D, Macherner R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980; 90: 810-816.
5. McCuen BW, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981; 91: 785-788.
6. Schindler RH, Chandler D, Thresher R, Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 1982; 93: 415-417.
7. Jonas JB, Kreissig I, Degenring RF. Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 2003; 121: 1663-1664.
8. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003; 110: 681-686.
9. Jonas JB. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 2004; 137: 560-562.
10. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetionide on intraocular pressure. Ophthalmic Surg Lasers Imaging 2003; 34: 386-390.
11. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ J Ophthalmol 1999; 27: 431-432.
12. Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua, W et al. Safety of an intravitreal injection of triamcinolone: Results from a randomised clinical trial. Arch Ophthalmol 2004; 122: 336-340.
13. Moshfegi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinisterra JP et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136: 791-796.
14. Nelson ML, Tennant MTS, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003; 23: 686-691.
15. Andrade RE, Muccioli C, Farah ME, Nussenblatt RB, Belfort R. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2004; 137: 572-574.
16. Jonas JB. Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia. Am J Ophthalmol 2004; 137: 367-368.
17. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24-27.